Can you provide the average price target for BIOHAVEN LTD stock?
24 analysts have analysed BHVN and the average price target is 21.36 USD. This implies a price increase of 148.04% is expected in the next year compared to the current price of 8.61.
NYSE:BHVN • VGG1110E1079
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOHAVEN LTD (BHVN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-11 | TD Cowen | Maintains | Buy -> Buy |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2026-03-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-21 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2026-01-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-12-03 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-11-26 | UBS | Downgrade | Buy -> Neutral |
| 2025-11-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-18 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-06 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-11-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-05 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-09-17 | Citigroup | Initiate | Buy |
| 2025-09-16 | UBS | Maintains | Buy -> Buy |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-08-19 | BTIG | Maintains | Buy -> Buy |
| 2025-08-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-08-12 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-12 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 200.36% | N/A 142.03% | N/A 136.32% | N/A 107.32% | N/A 17.34% | N/A 34.62% | ||||||||||||
| EBITDA YoY % growth | -9.7M | -60.62M -524.95% | N/A -97.59% | N/A -88.72% | N/A -91.02% | -114.44M 73.50% | -217.51M -90.06% | -566.54M -160.47% | -429.139M 24.25% | -877.256M -104.42% | -735.456M 16.16% | N/A 47.60% | N/A 0.01% | N/A 4.72% | N/A 20.59% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.7M | -60.63M -525.05% | -107.58M -77.44% | -224.55M -108.73% | -374.12M -66.61% | -114.51M 69.39% | -218.9M -91.16% | -567.93M -159.45% | -436.051M 23.22% | -885.111M -102.98% | -745.378M 15.79% | N/A 38.82% | N/A 5.74% | N/A 28.59% | N/A 19.05% | N/A 138.35% | N/A 470.24% | N/A 7.15% | N/A 70.49% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -6.19 -7.59% | -8.52 -37.64% | -12.51 -46.83% | -13.08 -4.56% | N/A 31.13% | -5.66 37.17% | -9.39 -65.90% | -6.96 25.88% | N/A 48.88% | N/A 30.09% | N/A 24.75% | N/A 97.06% | N/A 6,574.95% | N/A 115.04% | N/A -69.35% | N/A 67.39% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 61.03% | -1.12 42.10% | -1.00 39.30% | -0.95 21.81% |
| Revenue Q2Q % growth | 599.76K | 1.874M | 2.701M | 5.539M |
| EBITDA Q2Q % growth | -102.486M 53.27% | -116.711M 43.75% | -104.827M 35.30% | N/A |
| EBIT Q2Q % growth | -124.106M 43.99% | -157.997M 25.37% | -146.042M 13.78% | -145.478M -1.92% |
All data in USD
24 analysts have analysed BHVN and the average price target is 21.36 USD. This implies a price increase of 148.04% is expected in the next year compared to the current price of 8.61.
BIOHAVEN LTD (BHVN) will report earnings on 2026-05-11.
The consensus EPS estimate for the next earnings of BIOHAVEN LTD (BHVN) is -0.85 USD and the consensus revenue estimate is 599.76K USD.